Mika Saarela

Efficacy and safety of Privigen^® in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single‐arm, open‐label Phase <scp>III</scp> study (the <scp>PRIMA</scp> study)

Jean‐Marc Léger, Jan De Bleecker, Claudia Sommer et al. · Journal of the Peripheral Nervous System · 2013 · 76 citations · Full text

Medicine, Neurology, Pharmacotherapy +12

Hemophagocytic lymphohistiocytosis in 2 patients with multiple sclerosis treated with alemtuzumab

Mika Saarela, Keerthi Senthil, Joanne Jones et al. · Neurology · 2018 · 40 citations

Life Sciences, Immunology, Pharmacology +14

Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies

Ingemar S. J. Merkies, Ivo N. van Schaik, Jean‐Marc Léger et al. · Journal of the Peripheral Nervous System · 2019 · 32 citations · Full text

Medicine, Neurology, Pharmacotherapy +15

Geriatric rehabilitation as an integral part of geriatric medicine in the Nordic countries.

Yngve Gustafson, Marianne Schroll, Finn Rønholt Hansen et al. · PubMed · 2003 · 31 citations

Medicine, Geriatric Medicine, Rehabilitation Medicine +15

Altered immune landscape of cervical lymph nodes reveals Epstein-Barr virus signature in multiple sclerosis

Joona Sarkkinen, Dawit Yohannes, Nea Kreivi et al. · Science Immunology · 2025 · 18 citations

Life Sciences, Immunology, Infectious Diseases +17